| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 12.91% | Raymond James | $47 → $55 | Maintains | Outperform |
| 05/01/2023 | -3.51% | Raymond James | $44 → $47 | Maintains | Outperform |
| 04/06/2023 | -9.67% | Raymond James | $55 → $44 | Maintains | Outperform |
| 04/06/2023 | 19.07% | Keefe, Bruyette & Woods | $62 → $58 | Maintains | Outperform |
| 02/21/2023 | 12.91% | Raymond James | → $55 | Downgrades | Strong Buy → Outperform |
| 01/30/2023 | -1.46% | Wedbush | $42 → $48 | Maintains | Neutral |
| 01/30/2023 | 12.91% | Raymond James | $50 → $55 | Maintains | Strong Buy |
| 01/27/2023 | 2.65% | Piper Sandler | $47 → $50 | Maintains | Overweight |
| 10/31/2022 | 2.65% | Raymond James | $52 → $50 | Maintains | Strong Buy |
| 07/11/2022 | 14.97% | Keefe, Bruyette & Woods | $52 → $56 | Upgrades | Market Perform → Outperform |
| 06/30/2022 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 05/02/2022 | 6.75% | Raymond James | $62 → $52 | Maintains | Strong Buy |
| 01/28/2022 | 27.28% | B. Riley Securities | → $62 | Upgrades | Neutral → Buy |
| 11/01/2021 | 23.18% | Raymond James | $55 → $60 | Maintains | Strong Buy |
| 10/06/2021 | 10.86% | B. Riley Securities | → $54 | Downgrades | Buy → Neutral |
| 08/02/2021 | 12.91% | Raymond James | $53 → $55 | Maintains | Strong Buy |
| 05/03/2021 | 8.81% | Raymond James | $48 → $53 | Maintains | Strong Buy |
| 04/30/2021 | 10.86% | Janney Montgomery Scott | → $54 | Upgrades | Neutral → Buy |
| 03/22/2021 | 10.86% | Janney Montgomery Scott | $48 → $54 | Downgrades | Buy → Neutral |
| 02/01/2021 | -1.46% | Raymond James | $32 → $48 | Maintains | Strong Buy |
| 01/15/2021 | — | Janney Montgomery Scott | Initiates Coverage On | → Buy | |
| 11/02/2020 | -34.31% | Raymond James | $28.5 → $32 | Maintains | Strong Buy |
| 09/18/2020 | -46.62% | Piper Sandler | $25 → $26 | Maintains | Overweight |
| 08/27/2020 | -41.49% | Raymond James | $26 → $28.5 | Maintains | Strong Buy |
| 07/30/2020 | -48.68% | Piper Sandler | $24 → $25 | Maintains | Overweight |
| 05/15/2020 | -52.78% | Raymond James | $27 → $23 | Reiterates | → Strong Buy |
| 05/01/2020 | -44.57% | Raymond James | $19 → $27 | Maintains | Strong Buy |
| 04/13/2020 | -42.52% | B. Riley Securities | $39 → $28 | Maintains | Buy |
| 12/18/2019 | -28.15% | Wedbush | → $35 | Initiates Coverage On | → Outperform |
| 07/31/2019 | — | Compass Point | Upgrades | Neutral → Buy | |
| 05/01/2019 | — | Compass Point | Downgrades | Buy → Neutral | |
| 02/06/2019 | -21.99% | Compass Point | $33 → $38 | Upgrades | Neutral → Buy |
| 10/03/2018 | -5.56% | Raymond James | → $46 | Upgrades | Outperform → Strong Buy |
What is the target price for Axos Financial (AX)?
The latest price target for Axos Financial (NYSE: AX) was reported by Raymond James on July 31, 2023. The analyst firm set a price target for $55.00 expecting AX to rise to within 12 months (a possible 12.91% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axos Financial (AX)?
The latest analyst rating for Axos Financial (NYSE: AX) was provided by Raymond James, and Axos Financial maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Axos Financial (AX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axos Financial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axos Financial was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
Is the Analyst Rating Axos Financial (AX) correct?
While ratings are subjective and will change, the latest Axos Financial (AX) rating was a maintained with a price target of $47.00 to $55.00. The current price Axos Financial (AX) is trading at is $48.71, which is within the analyst's predicted range.